{"id":10065,"date":"2021-04-08T15:42:46","date_gmt":"2021-04-08T14:42:46","guid":{"rendered":"https:\/\/ppr-antibioresistance.inserm.fr\/?p=10065"},"modified":"2021-10-11T15:14:05","modified_gmt":"2021-10-11T14:14:05","slug":"2021-declaration-of-the-european-patient-group-on-antimicrobial-resistance","status":"publish","type":"post","link":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/2021-declaration-of-the-european-patient-group-on-antimicrobial-resistance\/","title":{"rendered":"2021 Declaration of the European Patient Group on Antimicrobial Resistance"},"content":{"rendered":"\n<p>Article published on <a href=\"http:\/\/healthfirsteurope.eu\/news\/2021-declaration-of-the-european-patient-group-on-antimicrobial-resistance\/\" target=\"_blank\" rel=\"noreferrer noopener\">Health First Europe website<\/a>, on April7, 2021<\/p>\n\n\n\n<p>On the&nbsp;<a href=\"https:\/\/www.who.int\/westernpacific\/news\/events\/world-health-day\" target=\"_blank\" rel=\"noreferrer noopener\">World Health Day 2021<\/a>, Health First Europe along with the members of the European Patient Group on Antimicrobial Resistance (<a href=\"http:\/\/healthfirsteurope.eu\/topic\/amr-patient-group\/\" target=\"_blank\" rel=\"noreferrer noopener\">AMR Patient Group<\/a>), launched their 2021&nbsp;<strong>Declaration on AMR,<\/strong>&nbsp;being truly committed to raising awareness about the real-world impact of antimicrobial resistance (AMR) and healthcare-associated infections (HAIs). Consequently, we strive to help reduce the inappropriate use of existing antibiotics, promote antimicrobial stewardship and infection prevention and control measures across Europe, and develop novel antibiotics where needed.<\/p>\n\n\n\n<p>Unfortunately, AMR remains one of the biggest threats to public health today and a challenge for Europe.&nbsp;<a href=\"https:\/\/www.ecdc.europa.eu\/en\/news-events\/antimicrobial-resistance-and-consumption-remains-high-press-release\">Data<\/a>&nbsp;from the European Centre for Disease Control and Prevention (ECDC) on AMR in 2019 demonstrated that percentages of resistance to vancomycin \u2013 a last-line antibiotic \u2013 in Enterococcus faecium bloodstream infections almost doubled between 2015 and 2019. Resistance to carbapenems \u2013 another group of last-line antibiotics \u2013&nbsp; also remains a serious concern. Indeed, even as we continue to develop new and effective antibiotics, appropriate antimicrobial stewardship of existing antibiotics as well as regular diagnostic testing remains highly important.<\/p>\n\n\n\n<p>The COVID-19 pandemic has underlined the need to understand the complex connections between bacterial and viral infections. AMR will likely increase through the heavy use of antibiotics in COVID-19 patient treatment. Hence, the importance of diagnosing, encouraging a more responsible behaviour and promoting the optimal prescription and sustainable use of antibiotics. As a result, there will be stronger preparedness for our healthcare systems and timely responses to this public health challenge.<\/p>\n\n\n\n<p>AMR is driven by interrelated dynamics in the human, animal and environmental health sectors, hence the importance of implementing national \u201cOne Health\u201d action plans against AMR.<\/p>\n\n\n\n<p>The purpose of this Declaration is to empower European citizens and patients to speak with one voice when sharing personal and group insights and experiences regarding the real-world impact of AMR and HAIs. The Declaration further calls upon European and national authorities to urgently commit to a&nbsp;<strong>full range of interventions in the field of education, prevention and investment<\/strong>. It is now more urgent than ever to step up actions to prevent HAIs and the related development of AMR throughout the patient journey.<\/p>\n\n\n\n<p><strong>You can find the Declaration and a new infographic attached below:<\/strong><\/p>\n\n\n\n<p><a href=\"http:\/\/healthfirsteurope.eu\/wp-content\/uploads\/2021\/04\/HFE-AMR-Patient-Group-Final-Declaration.pdf\" target=\"_blank\" rel=\"noreferrer noopener\">&nbsp;2021 AMR Patient Group Declaration<\/a><a href=\"http:\/\/healthfirsteurope.eu\/wp-content\/uploads\/2021\/04\/Antimicrobial-Resistance-Infographic-2.png\">&nbsp;<\/a><\/p>\n\n\n\n<p><a href=\"http:\/\/healthfirsteurope.eu\/wp-content\/uploads\/2021\/04\/Antimicrobial-Resistance-Infographic-2.png\">Antimicrobial Resistance <\/a><a href=\"http:\/\/healthfirsteurope.eu\/wp-content\/uploads\/2021\/04\/Antimicrobial-Resistance-Infographic-2.png\" target=\"_blank\" rel=\"noreferrer noopener\">infographic<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Article published on Health First Europe website, on April7, 2021 On the&nbsp;World Health Day 2021, Health First Europe along with the members of the European Patient Group on Antimicrobial Resistance (AMR Patient Group), launched their 2021&nbsp;Declaration on AMR,&nbsp;being truly committed to raising awareness about the real-world impact of antimicrobial resistance (AMR) and healthcare-associated infections (HAIs). [&hellip;]<\/p>\n","protected":false},"author":139,"featured_media":10073,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_links_to":"","_links_to_target":""},"categories":[31],"tags":[],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.8 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>2021 Declaration of the European Patient Group on Antimicrobial Resistance - French\u00a0National ANTIBIOTIC RESISTANCE Portal<\/title>\n<meta name=\"description\" content=\"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l&#039;Antibior\u00e9sistance en France et \u00e0 l&#039;international.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/2021-declaration-of-the-european-patient-group-on-antimicrobial-resistance\/\" \/>\n<meta property=\"og:locale\" content=\"en_GB\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"2021 Declaration of the European Patient Group on Antimicrobial Resistance - French\u00a0National ANTIBIOTIC RESISTANCE Portal\" \/>\n<meta property=\"og:description\" content=\"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l&#039;Antibior\u00e9sistance en France et \u00e0 l&#039;international.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/2021-declaration-of-the-european-patient-group-on-antimicrobial-resistance\/\" \/>\n<meta property=\"og:site_name\" content=\"French\u00a0National ANTIBIOTIC RESISTANCE Portal\" \/>\n<meta property=\"article:published_time\" content=\"2021-04-08T14:42:46+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2021-10-11T14:14:05+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2021\/04\/Mains-tendues.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"958\" \/>\n\t<meta property=\"og:image:height\" content=\"644\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"\u00c9milie Noguez\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"\u00c9milie Noguez\" \/>\n\t<meta name=\"twitter:label2\" content=\"Estimated reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"NewsArticle\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/2021-declaration-of-the-european-patient-group-on-antimicrobial-resistance\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/2021-declaration-of-the-european-patient-group-on-antimicrobial-resistance\/\"},\"author\":{\"name\":\"\u00c9milie Noguez\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#\/schema\/person\/6ae79ca06cbeaec66ef5e976b54606b3\"},\"headline\":\"2021 Declaration of the European Patient Group on Antimicrobial Resistance\",\"datePublished\":\"2021-04-08T14:42:46+00:00\",\"dateModified\":\"2021-10-11T14:14:05+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/2021-declaration-of-the-european-patient-group-on-antimicrobial-resistance\/\"},\"wordCount\":389,\"publisher\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#organization\"},\"image\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/2021-declaration-of-the-european-patient-group-on-antimicrobial-resistance\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2021\/04\/Mains-tendues.jpg\",\"articleSection\":[\"Actualit\u00e9s\"],\"inLanguage\":\"en-GB\"},{\"@type\":[\"WebPage\",\"ItemPage\"],\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/2021-declaration-of-the-european-patient-group-on-antimicrobial-resistance\/\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/2021-declaration-of-the-european-patient-group-on-antimicrobial-resistance\/\",\"name\":\"2021 Declaration of the European Patient Group on Antimicrobial Resistance - French\u00a0National ANTIBIOTIC RESISTANCE Portal\",\"isPartOf\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/2021-declaration-of-the-european-patient-group-on-antimicrobial-resistance\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/2021-declaration-of-the-european-patient-group-on-antimicrobial-resistance\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2021\/04\/Mains-tendues.jpg\",\"datePublished\":\"2021-04-08T14:42:46+00:00\",\"dateModified\":\"2021-10-11T14:14:05+00:00\",\"description\":\"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l'Antibior\u00e9sistance en France et \u00e0 l'international.\",\"breadcrumb\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/2021-declaration-of-the-european-patient-group-on-antimicrobial-resistance\/#breadcrumb\"},\"inLanguage\":\"en-GB\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/2021-declaration-of-the-european-patient-group-on-antimicrobial-resistance\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/2021-declaration-of-the-european-patient-group-on-antimicrobial-resistance\/#primaryimage\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2021\/04\/Mains-tendues.jpg\",\"contentUrl\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2021\/04\/Mains-tendues.jpg\",\"width\":958,\"height\":644,\"caption\":\"Cr\u00e9dit : Pixabay\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/2021-declaration-of-the-european-patient-group-on-antimicrobial-resistance\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Practical info &amp; communications\",\"item\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"News\",\"item\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/news\/\"},{\"@type\":\"ListItem\",\"position\":4,\"name\":\"2021 Declaration of the European Patient Group on Antimicrobial Resistance\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#website\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/\",\"name\":\"French\u00a0National ANTIBIOTIC RESISTANCE Portal\",\"description\":\"INSERM - From science to health\",\"publisher\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-GB\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#organization\",\"name\":\"Inserm\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/05\/logo-inserm-ppra.svg\",\"contentUrl\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/05\/logo-inserm-ppra.svg\",\"width\":1,\"height\":1,\"caption\":\"Inserm\"},\"image\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#\/schema\/person\/6ae79ca06cbeaec66ef5e976b54606b3\",\"name\":\"\u00c9milie Noguez\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"2021 Declaration of the European Patient Group on Antimicrobial Resistance - French\u00a0National ANTIBIOTIC RESISTANCE Portal","description":"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l'Antibior\u00e9sistance en France et \u00e0 l'international.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/2021-declaration-of-the-european-patient-group-on-antimicrobial-resistance\/","og_locale":"en_GB","og_type":"article","og_title":"2021 Declaration of the European Patient Group on Antimicrobial Resistance - French\u00a0National ANTIBIOTIC RESISTANCE Portal","og_description":"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l'Antibior\u00e9sistance en France et \u00e0 l'international.","og_url":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/2021-declaration-of-the-european-patient-group-on-antimicrobial-resistance\/","og_site_name":"French\u00a0National ANTIBIOTIC RESISTANCE Portal","article_published_time":"2021-04-08T14:42:46+00:00","article_modified_time":"2021-10-11T14:14:05+00:00","og_image":[{"width":958,"height":644,"url":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2021\/04\/Mains-tendues.jpg","type":"image\/jpeg"}],"author":"\u00c9milie Noguez","twitter_card":"summary_large_image","twitter_misc":{"Written by":"\u00c9milie Noguez","Estimated reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"NewsArticle","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/2021-declaration-of-the-european-patient-group-on-antimicrobial-resistance\/#article","isPartOf":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/2021-declaration-of-the-european-patient-group-on-antimicrobial-resistance\/"},"author":{"name":"\u00c9milie Noguez","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#\/schema\/person\/6ae79ca06cbeaec66ef5e976b54606b3"},"headline":"2021 Declaration of the European Patient Group on Antimicrobial Resistance","datePublished":"2021-04-08T14:42:46+00:00","dateModified":"2021-10-11T14:14:05+00:00","mainEntityOfPage":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/2021-declaration-of-the-european-patient-group-on-antimicrobial-resistance\/"},"wordCount":389,"publisher":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#organization"},"image":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/2021-declaration-of-the-european-patient-group-on-antimicrobial-resistance\/#primaryimage"},"thumbnailUrl":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2021\/04\/Mains-tendues.jpg","articleSection":["Actualit\u00e9s"],"inLanguage":"en-GB"},{"@type":["WebPage","ItemPage"],"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/2021-declaration-of-the-european-patient-group-on-antimicrobial-resistance\/","url":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/2021-declaration-of-the-european-patient-group-on-antimicrobial-resistance\/","name":"2021 Declaration of the European Patient Group on Antimicrobial Resistance - French\u00a0National ANTIBIOTIC RESISTANCE Portal","isPartOf":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/2021-declaration-of-the-european-patient-group-on-antimicrobial-resistance\/#primaryimage"},"image":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/2021-declaration-of-the-european-patient-group-on-antimicrobial-resistance\/#primaryimage"},"thumbnailUrl":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2021\/04\/Mains-tendues.jpg","datePublished":"2021-04-08T14:42:46+00:00","dateModified":"2021-10-11T14:14:05+00:00","description":"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l'Antibior\u00e9sistance en France et \u00e0 l'international.","breadcrumb":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/2021-declaration-of-the-european-patient-group-on-antimicrobial-resistance\/#breadcrumb"},"inLanguage":"en-GB","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/2021-declaration-of-the-european-patient-group-on-antimicrobial-resistance\/"]}]},{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/2021-declaration-of-the-european-patient-group-on-antimicrobial-resistance\/#primaryimage","url":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2021\/04\/Mains-tendues.jpg","contentUrl":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2021\/04\/Mains-tendues.jpg","width":958,"height":644,"caption":"Cr\u00e9dit : Pixabay"},{"@type":"BreadcrumbList","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/2021-declaration-of-the-european-patient-group-on-antimicrobial-resistance\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/"},{"@type":"ListItem","position":2,"name":"Practical info &amp; communications","item":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/"},{"@type":"ListItem","position":3,"name":"News","item":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/news\/"},{"@type":"ListItem","position":4,"name":"2021 Declaration of the European Patient Group on Antimicrobial Resistance"}]},{"@type":"WebSite","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#website","url":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/","name":"French\u00a0National ANTIBIOTIC RESISTANCE Portal","description":"INSERM - From science to health","publisher":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-GB"},{"@type":"Organization","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#organization","name":"Inserm","url":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#\/schema\/logo\/image\/","url":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/05\/logo-inserm-ppra.svg","contentUrl":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/05\/logo-inserm-ppra.svg","width":1,"height":1,"caption":"Inserm"},"image":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#\/schema\/person\/6ae79ca06cbeaec66ef5e976b54606b3","name":"\u00c9milie Noguez"}]}},"publishpress_future_action":{"enabled":false,"date":"2026-04-17 07:36:07","action":"change-status","newStatus":"private","terms":[],"taxonomy":"category"},"post_mailing_queue_ids":[],"_links":{"self":[{"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/posts\/10065"}],"collection":[{"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/users\/139"}],"replies":[{"embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/comments?post=10065"}],"version-history":[{"count":8,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/posts\/10065\/revisions"}],"predecessor-version":[{"id":17891,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/posts\/10065\/revisions\/17891"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/media\/10073"}],"wp:attachment":[{"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/media?parent=10065"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/categories?post=10065"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/tags?post=10065"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}